找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Drug Resistance; Beverly A. Teicher Book 2006 Humana Press 2006 angiogenesis.cancer.cytotoxicity.drug.drug resistance.hormones.imag

[復(fù)制鏈接]
樓主: 調(diào)停
11#
發(fā)表于 2025-3-23 11:18:47 | 只看該作者
12#
發(fā)表于 2025-3-23 16:36:57 | 只看該作者
13#
發(fā)表于 2025-3-23 19:14:06 | 只看該作者
Cisplatin Resistances coexist to create a complex multifaceted dilemma, which confounds cancer treatment strategies. However, additional platinumbased agents with different spectrums of antitumor activity are entering the clinic, but it is likely that more-potent leads may be identified from among the large reservoir o
14#
發(fā)表于 2025-3-24 01:24:48 | 只看該作者
The Cycle Between Angiogenesis, Perfusion, and Hypoxia in Tumorsance, enhanced invasion, and metastasis. Results indicate that concurrent targeting of both tumor and endothelial cells may be of central importance in improving treatment responses to both radiation and chemotherapy.
15#
發(fā)表于 2025-3-24 03:01:40 | 只看該作者
Tumor Oxygenation and Treatment Responsession. This chapter discusses recent research focused on methods of measuring tumor hypoxia accurately and extensively, with the aim of tailoring treatment on an individual patient basis. Examples of therapeutic approaches designed to exploit tumor hypoxia directly or indirectly, are discussed.
16#
發(fā)表于 2025-3-24 09:08:57 | 只看該作者
17#
發(fā)表于 2025-3-24 10:42:00 | 只看該作者
Book 2006 and tumor suppressor genes in therapeutic resistance, cancer stem cells, and the development of more effective therapies. There are also new findings on tumor immune escape mechanisms, gene amplification in drug resistance, the molecular determinants of multidrug resistance, and resistance to taxanes and Herceptin.
18#
發(fā)表于 2025-3-24 17:00:20 | 只看該作者
19#
發(fā)表于 2025-3-24 22:51:12 | 只看該作者
Tumor Site Implantation and Animal Model Selection in Oncologypretation of result with early stage drug candidates must be carefully considered..In this chapter, we review a number of studies that support the notion that tumor implantation site represents a critical determinant for the successful and meaningful efficacy evaluation of chemotherapeutic agents.
20#
發(fā)表于 2025-3-25 02:22:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
广丰县| 武安市| 浦城县| 兴义市| 卢氏县| 乳源| 濉溪县| 隆尧县| 弥勒县| 随州市| 浦东新区| 淳安县| 吕梁市| 沅陵县| 庆元县| 凤冈县| 邵武市| 阿克陶县| 双江| 文成县| 会东县| 丰原市| 临海市| 团风县| 彭阳县| 崇礼县| 贵港市| 怀集县| 隆化县| 葫芦岛市| 大悟县| 宁城县| 四川省| 连平县| 柘荣县| 广丰县| 通城县| 图们市| 桃源县| 清水河县| 环江|